Business Wire

The Qt Company Announces the Qt Automotive Suite

Del

Today, The Qt Company, creators of the Qt cross-platform development framework, together with its partners KDAB and Pelagicore announced the Qt Automotive Suite, a new product to support common In-Vehicle-Infotainment (IVI) system development needs of automotive OEMs and Tier1’s.

Today’s automakers and suppliers want to deliver an in-car experience that keeps drivers connected and informed. An experience where they can leverage a range of devices, services and where drivers can extend their work and their home into their vehicle through the connected car. Software technology is shaping the future of automotive and the user experience is what is in focus.

By combining proven components and tools used in the industry into a single offering, The Qt Automotive Suite meets the needs of automotive software solution providers with a ready-made offering. The solution is built on the Qt toolkit which encompasses libraries, tools, hardware adaptation and ready-made components. Qt is already a tried and tested mature tool within the industry powering the IVI systems of millions of cars on the road today. This new automotive development product will make it even easier and faster for OEMs and Tier1’s go to market.

Built upon the need of the automotive industry to consolidate an ever growing and complex supply chain, the Qt Automotive Suite aims to unite and simplify the tools and software components needed to create stunning, highly-performing and quickly adaptable IVI user interfaces devices.

“When building IVI systems, we see that many automotive manufacturers and providers are facing similar challenges with managing their technical solutions. The Qt Automotive Suite provides readily available components promising productivity and a high level of quality through world-class tools. This solution promises to make automotive development effortless where the UX and hardware and operating system flexibility is at the core, in turn allowing OEMs and Tier1’s concentrate on adding end-user value instead of tackling technical details.” says Petteri Holländer, Head of Product Management for the Qt Company.

The Qt Company, Pelagicore and KDAB have experience in delivering automotive UI software to over 20 automotive customers, and now they have joined their efforts in taking the Qt technology to the next level in the industry. Together, The Qt Company, KDAB and Pelagicore have created technology that elevates Qt from being a UI and application framework to being a full-fledged automotive UI software platform. Built on top of and aligned with the widely used GENIVI automotive platform architecture and leveraging the cross-platform nature of the Qt technology, there is a significant base of developers ready to take advantage of the new offering.

Qt Automotive Suite will be available under a dual-license scheme, both open source and commercial versions. The Qt Company also invites all interested parties to participate in defining related APIs under the Qt Project governance model.

“Qt Automotive Suite delivers a modern multi-process architecture enabling stunning fluid 2D and photo-realistic 3D user experiences in combination with cloud services. The dual licensing scheme enables car makers to develop an eco-system of innovation around their IVI offerings – from concept to production. We are proud to be a key contributor to Qt Automotive Suite.” says Alwin Bakkenes, CEO of Pelagicore.

“Platform-independent IVI and cluster software is a huge opportunity for the whole automotive industry. KDAB's and Pelagicore's experience with the leading industry platforms, together with the tried and true foundation that is the Qt framework, deliver an opportunity to unify the development of automotive applications, instead of doing them on a project-by-project basis,” says Kalle Dalheimer, CEO of KDAB.

More information about the Qt Automotive Suite will be presented at the Qt World Summit 2015 (Oct 6-7, Berlin) keynotes and in-depth technical strategy sessions. To register for the event, please visit www.qt.io.

For further company information please visit: About The Qt Company

To download the company logo please click here

# # #

October 2015 Ref: DQ162/A

Contact information

Contacts for Editorial Enquiries
The Qt Company
Petteri Holländer
Head of Product Management
+358 4 05 15 85 45
Petteri.Hollander@theqtcompany.com
or
Pinnacle Marketing Communications
Nevena Rasic
+44 (0) 2084 296 541
n.rasic@pinnaclemarcom.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar15.12.2017 22:13Pressemelding

Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 12:34Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712

Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 12:21Pressemelding

Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr

Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 11:38Pressemelding

A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L

Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 11:00Pressemelding

Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a

AML BitCoin Enters Phase II of ICO15.12.2017 09:00Pressemelding

NAC Foundation, LLC announces today that the initial coin offering for the AML BitCoin – the world’s only patent-pending compliant digital currency – has been extended for another month to accommodate a torrent of last minute, new coin purchasers and the demands of thousands of current owners of the coin, who have had difficulty navigating the process of establishing the specialized wallet required to hold the innovative digital currency. This second phase of the AML BitCoin initial coin offering will see an increase in the price of the coin, from US $1.00 to US $1.25. The company has already been contacted by prospective purchasers in the slightly higher priced Phase II, and anticipates a further price increase to US $1.50 within a week or two. HitBTC, one of the world’s largest and most active digital currency exchanges, was prepared to list the AML BitCoin for trading on

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom